UK results from the myeloproliferative neoplasms (MPN) landmark survey on the symptom, emotional and economic burden of MPN
Open Access
- 10 March 2019
- journal article
- letter
- Published by Wiley in British Journal of Haematology
- Vol. 186 (3) , E1-E4
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark surveyAnnals of Hematology, 2017
- Myeloproliferative neoplasms (MPNs) have a significant impact on patients’ overall health and productivity: the MPN Landmark surveyBMC Cancer, 2016
- The Patient Remote Intervention and Symptom Management System (PRISMS) – a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trialTrials, 2015
- Patients with polycythemia vera have worst impairment of quality of life among patients with newly diagnosed myeloproliferative neoplasmsLeukemia & Lymphoma, 2013
- Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNsJournal of Clinical Oncology, 2012
- Association between quality of life and clinical parameters in patients with myeloproliferative neoplasmsLeukemia & Lymphoma, 2011
- The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patientsBlood, 2011
- The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 1993